SOMAI
cultivating innovations
Somai Pharmaceuticals is an international company focused on the extraction of the Cannabis plant and making formulations for the EU market. Somai invests in extraction, cultivation, research, development and distribution of GMP-pharmaceutical certified cannabinoid products
Who We Are
Somaí Pharma is a medical model for the Cannabis industry, concentrating on growing and import/export of consistent high quality medical-grade flower and pharmacological applications with extracted 95% pure THC distillate and 99% THC-A isolate, which can be used for formulation of THC and CBD combinations for oral use like drops and pills.

Somaí Pharma will be best positioned for Global pharmaceutical distributors who reach
a broader demographic through world-wide networks and follows the successful model of Solaris Farms in the USA.
Our products
Our Presense
As more countries in the EU adopt medicinal Cannabis programs, we will be there to meet their demand. Rules and regulatory frameworks from the EU and independent countries are expanding rapidly and so will our partners and product lines.

We are on the cutting edge of developing exclusive partnerships with industry leaders in alternative medicine.
Join Our Partners List
If you are interested in becoming our partner,
join our partners list.
Our Latest News
Meet Our Team
George Bellow
CEO
Michael Sassano
CHAIRMAN OF THE BOARD
Roman Faizov
Business Development
Contact Us
hello@somaipharma.eu
We are present on:
Crunchbase | AngelList | Leafwire

Join our community and connect with us!
Join our Partners List
Enter your email and join our Partners list to receive news and updated about our products